News
Eyecare giant Alcon has bought a majority stake in cell therapy start-up Aurion Biotech, replacing the company's chief executive, in the culmination of a months-long struggle for control.
It goes before the assembly for consideration in May. Eyecare giant Alcon has bought a majority stake in cell therapy start-up Aurion Biotech, replacing the company's chief executive. In a new ...
Alcon’s majority acquisition of Aurion Biotech is a pivotal step in advancing cell therapy for corneal endothelial disease. Having been involved in this program early on, I’ve seen the rigor ...
Multinational eye care major Alcon is preparing to roll out multiple products in India over the coming months, in response to growing demand for advanced ophthalmic technologies and a strategic ...
Analysts use this formula to calculate it for Alcon: Return on Capital Employed = Earnings Before Interest and Tax (EBIT) ÷ (Total Assets - Current Liabilities) 0.049 = US$1.4b ÷ (US$30b - US$2 ...
To help fund these additions, we exited our position in Alcon (ALC), a medical device company focused on eye care products and solutions for surgical procedures and consumer use, and ...
No news stories today. Artemis Gold Inc. (V.ARTG) hit a new 52-week high of $19.75 Wednesday. No news stories today. Aurion Resources Ltd. (V.AU) hit a new 52-week high of 79 cents Wednesday. No news ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
The 2012 Toyota Aurion Sportivo ZR6 is Toyota’s most powerful, and largest family sedan currently on sale in Australia. It’s the bigger brother to the new Camry, featuring a 3.5-litre 200kW V6.
At close: April 17 at 5:31:31 p.m. GMT+2 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results